Summary In a double-blind, cross-more than trial, triazolam (0.25 mg) was tested towards flunitrazepam (1 mg) in the typical midwinter sleeplessness that is frequently observed amid in any other case nutritious people today in Northern Norway. Every drug was offered for 5 evenings, in random purchase, using a five-evening placebo period in between